Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ImmuneCyte is a joint venture between Healthbanks Biotech and ThermoGenesis. Healthbanks Biotech, established in 2001 and headquartered in Irvine, CA, is a dedicated to innovation and quality insurances in cell banking. ThermoGenesis (Nasdaq:KOOL), founded in 1986 in Sacramento, CA, is a major shareholder of the company. ThermoGenesis has pioneered in the field of cell banking, cell processing, and cell therapies. Its automate...
ImmuneCyte is a joint venture between Healthbanks Biotech and ThermoGenesis. Healthbanks Biotech, established in 2001 and headquartered in Irvine, CA, is a dedicated to innovation and quality insurances in cell banking. ThermoGenesis (Nasdaq:KOOL), founded in 1986 in Sacramento, CA, is a major shareholder of the company. ThermoGenesis has pioneered in the field of cell banking, cell processing, and cell therapies. Its automated cell processing platform is one of the world’s most advanced automated technology for the cell banking industry. More than 1,000,000 automated processing procedures have been performed worldwide.

List your booth number for exhibitions, ask us